Goodwin Charles D. II 4
4 · Apyx Medical Corp · Filed Feb 11, 2019
Insider Transaction Report
Form 4
Goodwin Charles D. II
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Option to Buy)
2019-01-09+236,000→ 236,000 totalExercise: $7.91From: 2022-01-09Exp: 2029-01-09→ Common Stock (236,000 underlying)
Footnotes (1)
- [F1]Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant.